Complement component 5a (C5a)

International Journal of Biochemistry and Cell Biology

Volumn 41, Issue 11, 2009, Pages 2114-2117

  Manthey, Helga D ^a   Woodruff, Trent M ^a   Taylor, Stephen M ^a   Monk, Peter N ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

C5a; C5a receptor antagonist; Complement system; Inflammation; Innate immunity

Indexed keywords

COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; COMPLEMENT INHIBITOR; ECULIZUMAB; PMX 205; PMX 53; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIPHOSPHOLIPID SYNDROME; BLOOD CLOTTING; CLINICAL TRIAL; COMPLEMENT ACTIVATION; CYTOKINE RELEASE; DEGENERATIVE DISEASE; ENTERITIS; HISTAMINE RELEASE; HUMAN; INFLAMMATION; INNATE IMMUNITY; NEOPLASM; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN STRUCTURE; PSORIASIS; REPERFUSION INJURY; RETINA MACULA AGE RELATED DEGENERATION; RHEUMATOID ARTHRITIS; SEPSIS; SHORT SURVEY; SYSTEMIC LUPUS ERYTHEMATOSUS;

AMINO ACID SEQUENCE; ANIMALS; COMPLEMENT C5A; HUMANS; MOLECULAR SEQUENCE DATA;

EID: 70349289120     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2009.04.005     Document Type: Short Survey

References (20)

1. Amara U., Rittirsch D., Flierl M., Bruckner U., Klos A., Gebhard F., et al. Interaction between the coagulation and complement system. Adv Exp Med Biol 632 (2008) 71-79
2. Bokisch V.A., and Muller-Eberhard H.J. Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase. J Clin Invest 49 (1970) 2427-2436
3. Chen N.J., Mirtsos C., Suh D., Lu Y.C., Lin W.J., McKerlie C., et al. C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a. Nature 446 (2007) 203-207
4. Chenoweth D.E., and Goodman M.G. The C5a receptor of neutrophils and macrophages. Agents Actions Suppl 12 (1983) 252-273
5. Gao H., Neff T.A., Guo R.F., Speyer C.L., Sarma J.V., Tomlins S., et al. Evidence for a functional role of the second C5a receptor C5L2. FASEB J 19 (2005) 1003-1005
6. Gerard N.P., Lu B., Liu P., Craig S., Fujiwara Y., Okinaga S., et al. An anti-inflammatory function for the complement anaphylatoxin C5a-binding protein, C5L2. J Biol Chem 280 (2005) 39677-39680
7. Guo R.F., and Ward P.A. Role of C5a in inflammatory responses. Annu Rev Immunol 23 (2005) 821-852
8. Higginbottom A., Cain S.A., Woodruff T.M., Proctor L.M., Madala P.K., Tyndall J.D., et al. Comparative agonist/antagonist responses in mutant human C5a receptors define the ligand binding site. J Biol Chem 280 (2005) 17831-17840
9. Kohl J. Self, non-self, and danger: a complementary view. Adv Exp Med Biol 586 (2006) 71-94
10. Markiewski M.M., DeAngelis R.A., Benencia F., Ricklin-Lichtsteiner S.K., Koutoulaki A., Gerard C., et al. Modulation of the antitumor immune response by complement. Nat Immunol 9 (2008) 1225-1235
11. Monk P.N., Scola A.M., Madala P., and Fairlie D.P. Function, structure and therapeutic potential of complement C5a receptors. Br J Pharmacol 152 (2007) 429-448
12. Morris K.M., Aden D.P., Knowles B.B., and Colten H.R. Complement biosynthesis by the human hepatoma-derived cell line HepG2. J Clin Invest 70 (1982) 906-913
13. Oppermann M., and Gotze O. Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors. Immunology 82 (1994) 516-521
14. Ricklin D., and Lambris J.D. Complement-targeted therapeutics. Nat Biotechnol 25 (2007) 1265-1275
15. Rittirsch D., Flierl M.A., Nadeau B.A., Day D.E., Huber-Lang M., Mackay C.R., et al. Functional roles for C5a receptors in sepsis. Nat Med 14 (2008) 551-557
16. Scola A.M., Johswich K.O., Morgan B.P., Klos A., and Monk P.N. The human complement fragment receptor, C5L2, is a recycling decoy receptor. Mol Immunol 46 (2009) 1149-1162
17. Shin H.S., Snyderman R., Friedman E., Mellors A., and Mayer M.M. Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig complement. Science 162 (1968) 361-363
18. Strainic M.G., Liu J., Huang D., An F., Lalli P.N., Muqim N., et al. Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. Immunity 28 (2008) 425-435
19. Wetsel R.A., Lemons R.S., Le Beau M.M., Barnum S.R., Noack D., and Tack B.F. Molecular analysis of human complement component C5: localization of the structural gene to chromosome 9. Biochemistry 27 (1988) 1474-1482
20. Woodruff T.M., Proctor L.M., Strachan A.J., and Taylor S.M. Complement factor 5a as a therapeutic target. Drugs Future 31 (2006) 325-334